Danske Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$920M Buy
767,326
+6,940
+0.9% +$7.09M 1.82% 11
2026
Q1
$699M Buy
760,386
+56,822
+8% +$57.6M 1.68% 10
2025
Q4
$756M Buy
703,564
+32,500
+5% +$31.1M 1.76% 10
2025
Q3
$512M Sell
671,064
-37,506
-5% -$27.9M 1.27% 12
2025
Q2
$552M Buy
708,570
+61,409
+9% +$47.7M 1.37% 11
2025
Q1
$534M Buy
647,161
+34,016
+6% +$28.3M 1.63% 8
2024
Q4
$473M Buy
613,145
+17,696
+3% +$14.7M 1.42% 10
2024
Q3
$528M Sell
595,449
-4,121
-0.7% -$3.7M 1.76% 7
2024
Q2
$543M Sell
599,570
-234,066
-28% -$187M 2% 7
2024
Q1
$649M Buy
+833,636
New +$593M 2.03% 7

Other funds holding LLY

Danske Bank's LLY Position: Q2 2026 in Review

Danske Bank increased its Eli Lilly (LLY) stake by 0.91% in Q2 2026, buying an estimated $7.09M and bringing the position to 767,326 shares worth $920M. The position accounts for 1.82% of the portfolio, ranked #11.

Danske Bank first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Danske Bank held 767,326 shares of Eli Lilly worth $920M as of Q2 2026.
  • Danske Bank bought 6,940 Eli Lilly shares in Q2 2026, an estimated $7.09M.
  • Eli Lilly made up 1.82% of Danske Bank's portfolio in Q2 2026, its #11 holding.
  • Danske Bank first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.